Siemens to boost drug discoveries using AI through the $5.1 billion acquisition of U.S. software firm Dotmatics
- Posted on April 3, 2025
- By Fortune
- 1 Views
Siemens to boost drug discoveries using AI through the $5.1 billion acquisition of U.S. software firm Dotmatics
Siemens said the acquisition was "complementary" to its expansion into life sciences and would lift its game in a market needing more medication innovation as populations age.
